Literature DB >> 5890449

[Clinical use of colimycin F otic solution].

S Nakajima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5890449

Source DB:  PubMed          Journal:  Jibiinkoka        ISSN： 0386-9679


× No keyword cloud information.
  3 in total

1.  In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.

Authors:  Kwang-sun Kim; Taeyeon Kim; Jae-Gu Pan
Journal:  J Antibiot (Tokyo)       Date:  2015-01-14       Impact factor: 2.649

2.  Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors:  Sofia K Kasiakou; Argyris Michalopoulos; Elpidoforos S Soteriades; George Samonis; George J Sermaides; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.

Authors:  Lorraine A Draper; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  BMC Microbiol       Date:  2013-09-26       Impact factor: 3.605
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.